West Hartford, CT, United States of America

Guillermo Kociubinski

This inventor holds 2 USPTO granted patents. Top assignee: Nestec S.a.. Active years: 2009-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guillermo Kociubinski. Retrieved from https://idiyas.com/inventor/guillermo-kociubinski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guillermo Kociubinski: Innovator in Endotoxin Binding Technologies

Introduction

Guillermo Kociubinski is a notable inventor based in West Hartford, CT (US). He has made significant contributions to the field of biotechnology, particularly in the area of endotoxin binding by lactic acid bacteria and bifidobacteria. With a total of 2 patents, Kociubinski's work has implications for both human health and pet food compositions.

Latest Patents

Kociubinski's latest patents focus on the use of lactic acid bacteria and bifidobacteria with hydrophobic surface properties. The first patent, titled "Endotoxin binding by lactic acid bacteria and bifidobacteria," relates to the preparation of a composition intended for the prevention or treatment of endotoxin-mediated disorders. The second patent, "Endotoxin binding lactic acid bacteria and bifidobacteria," shares a similar focus, emphasizing the potential applications in human and pet food compositions.

Career Highlights

Guillermo Kociubinski is currently associated with Nestec S.A., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential to improve health outcomes through the use of specific bacterial strains.

Collaborations

Kociubinski collaborates with Eduardo Schiffrin, contributing to advancements in their shared field of research.

Conclusion

Guillermo Kociubinski's innovative work in endotoxin binding technologies showcases his commitment to improving health through biotechnology. His patents reflect a significant step forward in the application of lactic acid bacteria and bifidobacteria in various compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…